With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Level Zero Health announced that it raised $6.9 million in a pre-seed funding round to support its remote, continuous ...

There are various blood sugar monitors for those with diabetes and it is important to have regular monitoring done. While ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

We have excluded third-party attorney’s fees, costs, and expenses incurred by Dexcom exclusively in connection with Dexcom’s patent infringement litigation against Abbott Diabetes Care, Inc., as ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Global Biohacking Market Set for Exponential Growth, Driven by Wearable Technology and Advanced DiagnosticsPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biohacking Market Size & Growth Analysis: ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...